Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Fish and Richardson
Deloitte
Novartis
Citi
Covington
Moodys
Farmers Insurance
Fuji
McKesson

Generated: August 21, 2017

DrugPatentWatch Database Preview

METHAZOLAMIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Methazolamide, and what generic Methazolamide alternatives are available?

Methazolamide is a drug marketed by Ani Pharms Inc, Sandoz, Applied Anal, and Mikart. and is included in five NDAs.

The generic ingredient in METHAZOLAMIDE is methazolamide. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the methazolamide profile page.

Summary for Tradename: METHAZOLAMIDE

Patents:0
Applicants:4
NDAs:5
Suppliers / Packagers: see list6
Bulk Api Vendors: see list53
Clinical Trials: see list6
Patent Applications: see list1,777
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:METHAZOLAMIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc
METHAZOLAMIDE
methazolamide
TABLET;ORAL040001-001Jun 30, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
METHAZOLAMIDE
methazolamide
TABLET;ORAL040036-001Jun 30, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
METHAZOLAMIDE
methazolamide
TABLET;ORAL040102-002Aug 28, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
METHAZOLAMIDE
methazolamide
TABLET;ORAL040036-002Jun 30, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
METHAZOLAMIDE
methazolamide
TABLET;ORAL040001-002Jun 30, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Cerilliant
US Department of Justice
Baxter
Fuji
Healthtrust
Johnson and Johnson
AstraZeneca
Novartis
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot